Youngmahn Han

Dr. Youngmahn Han

Korea Institute of Science and Technology Information

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Open access
SYSunyong Yoo
Sunyong Yoo
MJMyeonghyeon Jeong
Myeonghyeon Jeong
SSSubhin Seomun
Subhin Seomun
KKKiseong Kim
Kiseong Kim
YHYoungmahn Han
Youngmahn Han
The emergence of the novel coronavirus, designated as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has posed a significant threat to public health worldwide. There has been progress in reducing hospitalizations and deaths due to SARS-CoV-2. However, challenges stem from the emergence of SARS-CoV-2 variants, which exhibit high transmission rates, increased disease severity, and the ability to evade humoral immunity. Epitope-specific T-cell receptor (TCR) recognition is key in determining the T-cell immunogenicity for SARS-CoV-2 epitopes. Although several data-driven methods for predicting epitope-specific TCR recognition have been proposed, they remain challenging due to the enormous diversity of TCRs and the lack of available training data. Self-supervised transfer learning has recently been proven useful for extracting information from unlabeled protein sequences, increasing the predictive performance of fine-tuned models, and using a relatively small amount of training data. This study presents a deep-learning model generated by fine-tuning pre-trained protein embeddings from a large corpus of protein sequences. The fine-tuned model showed markedly high predictive performance and outperformed the recent Gaussian process-based prediction model. The output attentions captured by the deep-learning model suggested critical amino acid positions in the SARS-CoV-2 epitope-specific TCRβ sequences that are highly associated with the viral escape of T-cell immune response.

17 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYoungmahn Han
Youngmahn Han
ALAeri Lee
Aeri Lee
The COVID-19 pandemic is ongoing because of the high transmission rate and the emergence of SARS-CoV-2 variants. The P272L mutation in SARS-Cov-2 S -protein is known to be highly relevant to the viral escape associated with the second pandemic wave in Europe. Epitope-specific T-cell receptor (TCR) recognition is a key factor in determining the T-cell immunogenicity of a SARS-CoV-2 epitope. Although several data-driven methods for predicting epitope-specific TCR recognition have been proposed, they remain challenging owing to the enormous diversity of TCRs and the lack of available training data. Self-supervised transfer learning has recently been demonstrated to be powerful for extracting useful information from unlabeled protein sequences and increasing the predictive performance of the fine-tuned models in downstream tasks. Here, we present a predictive model based on Bidirectional Encoder Representations from Transformers (BERT), employing self-supervised transfer learning, to predict SARS-CoV-2 T-cell epitope-specific TCR recognition. The fine-tuned model showed notably high predictive performance for independent evaluation using the SARS-CoV-2 epitope-specific TCR CDR3β sequence datasets. In particular, we found the proline at position 4 corresponding to the P272L mutation in the SARS-CoV-2 S -protein 269-277 epitope ( YLQPRTFLL ) may contribute substantially to TCR recognition of the epitope through interpreting the output attention weights of our model. We anticipate that our findings will provide new directions for constructing a reliable data-driven model to predict the immunogenic T-cell epitopes using limited training data and help accelerate the development of an effective vaccine in response to SARS-CoV-2 variants.

21 July 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
JLJong Hyeon Lim
Jong Hyeon Lim
MKMyounwoo Kim
Myounwoo Kim
YHYoungmahn Han
Youngmahn Han
JLJi Ha Lee
Ji Ha Lee
Multi-modal drug discovery frameworks increasingly rely on robust encoders capable of representing chemical structures alongside other data modalities. In this study, we fine-tuned a DeBERTa-based SMILES encoder to improve its predictive capacity for 22 ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) endpoints while maintaining strong comprehension of molecular syntax. Starting from a pretrained ZINC-based DeBERTa checkpoint, we trained on a 300K PubChem-ADMET dataset using a multi-label regression scheme with a focal MAE loss to stabilize learning across diverse properties. Our encoder achieved top-10 rankings on 16 TDC benchmark tasks, including notable improvements of 14–30% on critical endpoints such as bioavailability and CYP2C9-substrate. Compared with BERT- and RoBERTa-based molecular encoders, our approach preserved significantly higher MLM accuracy (>89%) over training, indicating robust retention of chemical language understanding. Additional analysis using an ADMET path length metric revealed that DeBERTa produced more disentangled latent representations, underscoring its suitability for property-specific molecular manipulation. These results demonstrate that a disentangled, ADMET-aware DeBERTa encoder can serve as a powerful component for future multi-modal pipelines in AI-driven drug design, effectively balancing structural fluency with predictive specialization.

1 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
KPKavya Dasaramoole Prakash
Kavya Dasaramoole Prakash
KKKiseong Kim
Kiseong Kim
YHYoungmahn Han
Youngmahn Han
Medical Vision-Language Models (MVLMs) are emerging as powerful tools for tasks such as Visual Question Answering (VQA); however, they often struggle with hallucination and limited reasoning transparency, particularly in complex diagnostic scenarios. In this work, we enhance the MedVLM-R1 framework by fine-tuning it using clinically informed prompt structures tailored specifically for radiology-based reasoning. Without altering the original model architecture or training strategy, we redesign the system prompts and question templates to guide the model through structured, modality-aware, and step-by-step diagnostic reasoning. Fine-tuning is performed using MRI-based question-answer (QA) pairs, and evaluations are conducted across three diagnostic imaging: MRI, CT, and X-ray to assess both in-domain and out-of-domain generalization. Our approach improves reasoning transparency and accuracy, achieving 96.00% on MRI, 72.67% on CT, and 75.2% on X-ray. Compared to the original MedVLM-R1, our method closes the gap in MRI accuracy while significantly enhancing generalization performance on CT and X-ray modalities. These results demonstrate that clinically grounded prompting effectively improves both reasoning fidelity and robustness across imaging modalities. The code is available at our GitHub repository: https://github.com/aidanbio/AIdanMed